TScan Therapeutics (TCRX) Cash & Equivalents (2020 - 2026)
TScan Therapeutics (TCRX) recorded Cash & Equivalents of $100.2 million in Q2 2026, down 40.8% from $169.39 million a year earlier and down 21.8% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, TScan Therapeutics reported Cash & Equivalents of $152.41 million, down 14.7% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 34.4% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $178.69 million in FY2024 (+34.0%), $133.36 million in FY2023 (+11.1%), $120.03 million in FY2022 (-25.6%) and $161.41 million in FY2021 (+363.9%).
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q1 2023.
- On a year-over-year basis, Cash & Equivalents has declined for three consecutive quarters, with an average decline of 5.7% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 363.9% in Q4 2021, against a decline of 40.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $128.06 million (Q1 2026), $152.41 million (Q4 2025) and $169.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | TScan Therapeutics | 41.58 Mn | 41.58 Mn | - | 100.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.20 Mn |
| Mar 31, 2026 | 128.06 Mn |
| Dec 31, 2025 | 152.41 Mn |
| Sep 30, 2025 | 169.51 Mn |
| Jun 30, 2025 | 169.39 Mn |
| Mar 31, 2025 | 154.11 Mn |
| Dec 31, 2024 | 178.69 Mn |
| Sep 30, 2024 | 133.12 Mn |
| Jun 30, 2024 | 242.16 Mn |
| Mar 31, 2024 | 140.51 Mn |
| Dec 31, 2023 | 133.36 Mn |
| Sep 30, 2023 | 155.19 Mn |
| Jun 30, 2023 | 208.84 Mn |
| Mar 31, 2023 | 95.61 Mn |
| Dec 31, 2022 | 120.03 Mn |
| Sep 30, 2022 | 137.31 Mn |
| Jun 30, 2022 | 125.60 Mn |
| Mar 31, 2022 | 140.84 Mn |
| Dec 31, 2021 | 161.41 Mn |
| Sep 30, 2021 | 182.31 Mn |
API Access
TScan Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();